PharmaPoint: Venous Thromboembolism – Global Drug Forecast and Market Analysis to 2026

2017-06-01
Price :
Published : Jun-2017
No. of Pages : 203

PharmaPoint: Venous Thromboembolism – Global Drug Forecast and Market Analysis to 2026

Summary

Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from pulmonary embolism (PE) to deep vein thrombosis (DVT). The therapeutic landscape for VTE is divided into the VTE treatment setting and VTE primary prophylaxis, which is further divided into the prophylaxis for total knee replacement (TKR) and total hip replacement (THR) patients, as well as for acute medically ill patients. Antithrombotic therapy represents the cornerstone treatment strategy for all VTE patients. Presently, the established vitamin K antagonists (VKA) and low molecular weight heparins (LMWH) are the most widely prescribed drugs for VTE treatment and prophylaxis, where the historical dominance of these therapies has been the most prominent barrier towards VTE market evolution and growth.

It is estimated that sales of venous thromboembolism (VTE) therapeutics were approximately $1.95B across the seven major markets (7MM) in 2016, which includes the US, the five major European markets (5EU: France, Germany, Italy, Spain, and UK), and Japan. In the 2016 base year, 25% of market shares were attributed to the VTE treatment setting ($497M) and 75% to VTE primary prophylaxis treatments ($1.45B).

By 2026, it is expected that the VTE market to grow at a strong Compound Annual Growth Rate (CAGR) of 3.87%, reaching sales of $2.85B by the end of the forecast period. The main market contributing to the sustained growth over this forecast is the US, contributing $1.43B in sales in 2016, a figure that is anticipated to increase at a CAGR of 3.08% to $1.94B by 2026. Over this forecast, the most prominent wave of sales increases comes from the novel oral anticoagulant (NOAC) class, which is expected to peak at $1.04B in global sales by 2022, reflecting a 10-year CAGR of 3.91% by 2026, despite the generic erosion of several key players.

Major drivers of VTE market growth over the forecast period are the –
– Increase in patient shares towards the NOACs due to increased confidence among physicians about using these novel therapies.
– Launch of betrixaban for extended-duration prophylaxis in acute medically ill patients.
– Launch of the first Factor XI inhibitor, IONIS-FXIRX.
– Increase in the global prevalence of VTE.
– Launch of the Factor Xa reversal agents.

Major growth in the VTE market over the forecast period is caused by the rise in sales surrounding the VTE primary prophylaxis space, which increased from $1.45B in 2016 to $2.3B by 2026 at a CAGR of 4.66%. The VTE prophylaxis segment dominates the VTE space due to the much higher number of patients in need of prophylaxis compared to the number of patients in need of VTE treatment.

The report “PharmaPoint: Venous Thromboembolism – Global Drug Forecast and Market Analysis to 2026” provides an Overview of VTE, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.

In depth, this report provides the following –
– Annualized VTE therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2015 and forecast for ten years to 2025.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the VTE therapeutics market.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
– Analysis of the current and future market competition in the global VTE therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Companies mentioned in this report: Boehringer Ingelheim, Bayer, Janssen, BMS, Pfizer, Sanofi, Daiichi-Sankyo, Portola Pharmaceuticals, Ionis Therapeutics, Armetheon.

Scope

– Overview of VTE, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
– Annualized VTE therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2015 and forecast for ten years to 2025.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the VTE therapeutics market.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
– Analysis of the current and future market competition in the global VTE therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
– Develop business strategies by understanding the trends shaping and driving the global VTE therapeutics market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global VTE therapeutics market in future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track drug sales in the global VTE therapeutics market from 2016-2026.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

EU5 ICP Procedures Outlook to 2025

EU5 ICP Procedures Outlook to 2025 Summary GlobalData's new report, EU5 ICP Procedures Outlook to 2025, provides key procedures data on the EU5 ICP Procedures. The report provides procedure volumes within market segment - ICP Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence da......
$3995

Australia Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

Australia Neurology Procedures Outlook to 2025 - Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others Summary GlobalData's new report, Australia Neurology Procedures Outlook to 2025, provides key procedures data on the Australia Neurology Procedures. The report provides procedure volumes within market categories - Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Neuromodulation Procedures, Neurovascular Accessory Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Embolization Procedures and Neurovascular Thrombectomy Procedures The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecas......
$3995

Spain Patient Monitoring Accessories Market Outlook to 2025

Spain Patient Monitoring Accessories Market Outlook to 2025 Summary GlobalData's new report, Spain Patient Monitoring Accessories Market Outlook to 2025, provides key market data on the Spain Patient Monitoring Accessories market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Patient Monitoring Leads and Electrodes, Patient Monitoring Temperature Probes and Non-Invasive Blood Pressure Cuffs. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the repo......
$4995

Mexico Fetal Monitors Market Outlook to 2025

Mexico Fetal Monitors Market Outlook to 2025 Summary GlobalData's new report, Mexico Fetal Monitors Market Outlook to 2025, provides key market data on the Mexico Fetal Monitors market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Antepartum Monitors and Intrapartum Monitors. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate ......
$4995

Asia-Pacific Neuromodulation Procedures Outlook to 2025

Asia-Pacific Neuromodulation Procedures Outlook to 2025 Summary GlobalData's new report, Asia-Pacific Neuromodulation Procedures Outlook to 2025, provides key procedures data on the Asia-Pacific Neuromodulation Procedures. The report provides procedure volumes within market segments - Deep Brain Stimulators Procedures, Gastric Electric Stimulators Procedures, Peripheral Nerve Stimulators Procedures, Sacral Nerve Stimulators Procedures, Spinal Cord Stimulators Procedures and Vagus Nerve Stimulators Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiol......
$3995

United Kingdom Neonatal Monitors Market Outlook to 2025

United Kingdom Neonatal Monitors Market Outlook to 2025 Summary GlobalData's new report, United Kingdom Neonatal Monitors Market Outlook to 2025, provides key market data on the United Kingdom Neonatal Monitors market. The report provides value in millions of US dollars, volume (in units), average prices (USD) and company share within market segment. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate t......
$4995

South Korea Remote Patient Monitoring Market Outlook to 2025

South Korea Remote Patient Monitoring Market Outlook to 2025 Summary GlobalData's new report, South Korea Remote Patient Monitoring Market Outlook to 2025, provides key market data on the South Korea Remote Patient Monitoring market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - External Remote Patient Monitoring Devices and Implantable Remote Patient Monitoring Devices. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interv......
$4995

Canada Micro-Electromechanical Sensors Market Outlook to 2025

Canada Micro-Electromechanical Sensors Market Outlook to 2025 Summary GlobalData's new report, Canada Micro-Electromechanical Sensors Market Outlook to 2025, provides key market data on the Canada Micro-Electromechanical Sensors market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segment. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to valida......
$4995

North America Intracranial Stenting Procedures Outlook to 2025

North America Intracranial Stenting Procedures Outlook to 2025 Summary GlobalData's new report, North America Intracranial Stenting Procedures Outlook to 2025, provides key procedures data on the North America Intracranial Stenting Procedures. The report provides procedure volumes within market segment - Intracranial Stenting Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient populatio......
$3995

United Kingdom Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

United Kingdom Neurology Procedures Outlook to 2025 - Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others Summary GlobalData's new report, United Kingdom Neurology Procedures Outlook to 2025, provides key procedures data on the United Kingdom Neurology Procedures. The report provides procedure volumes within market categories - Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Neuromodulation Procedures, Neurovascular Accessory Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Embolization Procedures and Neurovascular Thrombectomy Procedures The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estim......
$3995
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy